| 000 | 01527 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513185607.0 | ||
| 264 | 0 | _c19990728 | |
| 008 | 199907s 0 0 eng d | ||
| 022 | _a0161-5505 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKitagawa, Y | |
| 245 | 0 | 0 |
_aFDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms. _h[electronic resource] |
| 260 |
_bJournal of nuclear medicine : official publication, Society of Nuclear Medicine _cJul 1999 |
||
| 300 |
_a1132-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdiagnostic imaging |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorine Radioisotopes |
| 650 | 0 | 4 | _aFluorodeoxyglucose F18 |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xdiagnostic imaging |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intra-Arterial |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm, Residual |
| 650 | 0 | 4 | _aRadiopharmaceuticals |
| 650 | 0 | 4 | _aRadiotherapy, High-Energy |
| 650 | 0 | 4 | _aTomography, Emission-Computed |
| 700 | 1 | _aSadato, N | |
| 700 | 1 | _aAzuma, H | |
| 700 | 1 | _aOgasawara, T | |
| 700 | 1 | _aYoshida, M | |
| 700 | 1 | _aIshii, Y | |
| 700 | 1 | _aYonekura, Y | |
| 773 | 0 |
_tJournal of nuclear medicine : official publication, Society of Nuclear Medicine _gvol. 40 _gno. 7 _gp. 1132-7 |
|
| 999 |
_c10363319 _d10363319 |
||